The real conspiracy in the pharma industryPaul Tunnah on how pharma industry workers can negatively affect patients without even realising it. If you work Share XThe real conspiracy in the pharma industryhttps://pharmaphorum.com/views-and-analysis/the-real-conspiracy-pharma-industry/
Building a new type of pharmaceutical company – a vision for pharma 2.0The definition of healthcare has become incredibly diverse since the turn of the century. It feels like it Share XBuilding a new type of pharmaceutical company – a vision for pharma 2.0https://pharmaphorum.com/views-analysis-sales-marketing/building-new-pharmaceutical-company-pharma-2-0/
Let’s talk about drugsPaul Tunnah asks if we need to rethink pharma’s strict marketing regulations and have a discussion on how Share XLet’s talk about drugshttps://pharmaphorum.com/views-and-analysis/lets-talk-drugs/
Can ‘design thinking’ revolutionise pharma’s culture?As part of pharmaphorum’s ‘eye-on-innovation’ series, Paul Tunnah speaks to UCB’s head of innovation, Gregory Miller, about how Share XCan ‘design thinking’ revolutionise pharma’s culture?https://pharmaphorum.com/views-and-analysis/can-design-thinking-revolutionise-pharmas-culture/
Merck KGaA celebrates 350 years of innovationAs part of pharmaphorum’s eye-on-innovation interview series, Paul Tunnah speaks to Merck Biopharma’s vice president of innovation Ulrich Share XMerck KGaA celebrates 350 years of innovationhttps://pharmaphorum.com/views-analysis-digital/merck-kgaa-celebrates-350-years-innovation/
Innovation, endpoints and education – what’s in store for pharma in future-healthcare?As part of pharmaphorum’s ‘eye-on-innovation’ interview series, Paul Tunnah speaks to Bayer’s Chief Marketing Officer Pharmaceuticals, Sebastian Guth, Share XInnovation, endpoints and education – what’s in store for pharma in future-healthcare?https://pharmaphorum.com/views-and-analysis/innovation-endpoints-education-whats-store-pharma-future-healthcare/
